173 related articles for article (PubMed ID: 31156170)
1. Associated Factors of Total Costs of Alzheimer's Disease: A Cluster-Randomized Observational Study in China.
Yan X; Li F; Chen S; Jia J
J Alzheimers Dis; 2019; 69(3):795-806. PubMed ID: 31156170
[TBL] [Abstract][Full Text] [Related]
2. The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
Jia J; Wei C; Chen S; Li F; Tang Y; Qin W; Zhao L; Jin H; Xu H; Wang F; Zhou A; Zuo X; Wu L; Han Y; Han Y; Huang L; Wang Q; Li D; Chu C; Shi L; Gong M; Du Y; Zhang J; Zhang J; Zhou C; Lv J; Lv Y; Xie H; Ji Y; Li F; Yu E; Luo B; Wang Y; Yang S; Qu Q; Guo Q; Liang F; Zhang J; Tan L; Shen L; Zhang K; Zhang J; Peng D; Tang M; Lv P; Fang B; Chu L; Jia L; Gauthier S
Alzheimers Dement; 2018 Apr; 14(4):483-491. PubMed ID: 29433981
[TBL] [Abstract][Full Text] [Related]
3. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
[TBL] [Abstract][Full Text] [Related]
4. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
[TBL] [Abstract][Full Text] [Related]
5. Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.
Li F; Chen S; Wei C; Jia J
BMC Neurol; 2017 Jan; 17(1):15. PubMed ID: 28122529
[TBL] [Abstract][Full Text] [Related]
6. Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
Tahami Monfared AA; Khachatryan A; Hummel N; Kopiec A; Martinez M; Zhang R; Zhang Q
J Alzheimers Dis; 2024; 99(1):191-206. PubMed ID: 38640156
[TBL] [Abstract][Full Text] [Related]
7. Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.
Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Treuer T; Sato M; Kahle-Wrobleski K; Meguro K; Yamada M; Mimura M; Arai H
J Alzheimers Dis; 2020; 74(1):127-138. PubMed ID: 31985460
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey.
Montgomery W; Goren A; Kahle-Wrobleski K; Nakamura T; Ueda K
BMC Geriatr; 2018 Jun; 18(1):141. PubMed ID: 29898679
[TBL] [Abstract][Full Text] [Related]
9. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
[TBL] [Abstract][Full Text] [Related]
10. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
[TBL] [Abstract][Full Text] [Related]
11. The economic impact of moderate stage Alzheimer's disease in Italy: evidence from the UP-TECH randomized trial.
Chiatti C; Furneri G; Rimland JM; Demma F; Bonfranceschi F; Cassetta L; Masera F; Cherubini A; Corsonello A; Lattanzio F;
Int Psychogeriatr; 2015 Sep; 27(9):1563-72. PubMed ID: 25874654
[TBL] [Abstract][Full Text] [Related]
12. The cost of Alzheimer's disease in managed care: a cross-sectional study.
Leon J; Neumann PJ
Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
[TBL] [Abstract][Full Text] [Related]
13. The Economic Burden of Alzheimer's Disease in Zhejiang Province.
Yu E; Liao Z; Fan W; Hu W; Tian G; Chen K; Chen S; Hua H; Zheng H; Fang X; Li G; Xie J; Wu S
J Alzheimers Dis; 2021; 80(2):539-553. PubMed ID: 33579844
[TBL] [Abstract][Full Text] [Related]
14. Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.
Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
Int Psychogeriatr; 2016 Feb; 28(2):247-59. PubMed ID: 26307191
[TBL] [Abstract][Full Text] [Related]
15. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
[TBL] [Abstract][Full Text] [Related]
16. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina.
Allegri RF; Butman J; Arizaga RL; Machnicki G; Serrano C; Taragano FE; Sarasola D; Lon L
Int Psychogeriatr; 2007 Aug; 19(4):705-18. PubMed ID: 16870037
[TBL] [Abstract][Full Text] [Related]
18. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients.
Beeri MS; Werner P; Davidson M; Noy S
Int J Geriatr Psychiatry; 2002 May; 17(5):403-8. PubMed ID: 11994927
[TBL] [Abstract][Full Text] [Related]
19. The clinical and economic burden among caregivers of patients with Alzheimer's disease in Canada.
Szabo S; Lakzadeh P; Cline S; Palma Dos Reis R; Petrella R
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1677-1688. PubMed ID: 31353572
[TBL] [Abstract][Full Text] [Related]
20. Cross sectional observational study on the societal costs of Alzheimer's disease.
Mesterton J; Wimo A; By A; Langworth S; Winblad B; Jönsson L
Curr Alzheimer Res; 2010 Jun; 7(4):358-67. PubMed ID: 19939223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
